SAN DIEGO--(BUSINESS WIRE)--April 24, 2006--Cytori Therapeutics, Inc. (NASDAQ:CYTX - News; Frankfurt:XMPA - News) announced today that adipose stem and regenerative cells, when administered in combination with a fat graft, improved survival of the transplanted tissue in a preclinical study. The study results were presented by Cytori scientist Min Zhu, M.D., at the 2006 American Society for Aesthetic Plastic Surgery (ASAPS) Meeting in Orlando, Florida.
